August 15, 2021

High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

MYL9 is upregulated in EOC and may serve as a useful patent of prognostic biomarker in EOC, and it may demonstrate an important value for the clinical treatment and supervision of patients with EOC.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Deng et al. (Sun,) studied this question.

synapsesocial.com/papers/69df1dbf3b0ba53fb37a16aa https://doi.org/https://doi.org/10.2174/1574891x16666210706153740

Preguntar a la IA

Me gusta

Guardar